Please assess the completion status of the following clinical trial:

Trial Title: Statin Contrast Induced Nephropathy Prevention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Are eligible for the study all patients admitted to CCU for Acute Coronary Syndrome without ST elevation (NSTEMI) candidates for early invasive strategy (coronary angiography within 48 hours from the admission) and without previous therapy with statins.~Exclusion Criteria:~1. inability to provide consent~2. pregnancy or lactation~3. intolerance to statins~4. therapy with other lipid lowering drugs~5. acute or chronic liver disease~6. chronic muscle disease~7. acute renal failure or chronic renal failure stage IV~8. neoplastic~9. exposure to iodinated contrast medium in the previous 10 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Rosuvastatin (Type: ACTIVE_COMPARATOR): None
- Control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).